Marla English-Pickett
Nurse Practitioner · Texarkana, TXNPI 1013163013
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 191 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,941 and has fallen 97.4% since, to $51 in 2023. Among nurse practitioner clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 191 payments — averaging $17.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$540
- AstraZeneca$455
- GSK$364
- Bayer$363
- Novo Nordisk$339
- Boehringer Ingelheim$309
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,411100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 32 | $540 |
| AstraZeneca | 17 | $455 |
| GSK | 19 | $364 |
| Bayer | 25 | $363 |
| Novo Nordisk | 18 | $339 |
| Boehringer Ingelheim | 16 | $309 |
| Pfizer | 11 | $182 |
| Lilly USA, LLC | 13 | $164 |
| Abbott | 7 | $119 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $90 |
| Biogen | 4 | $68 |
| Mylan Specialty L.p. | 3 | $56 |
| Vifor Pharma, Inc. | 2 | $53 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $50 |
| Johnson & Johnson | 3 | $38 |
| Bioventus LLC | 1 | $36 |
| Novartis | 2 | $33 |
| Amgen | 2 | $32 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| UCB, Inc. | 1 | $16 |
| Acadia Pharmaceuticals Inc | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Corcept Therapeutics | 1 | $15 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$125
- UBRELVY$117
- RYBELSUS$115
- Kerendia$109
How this compares
$3,418 in reported general payments places this provider in the 90th percentile of 5,422 nurse practitioner providers in Texas.
Other nurse practitioner in Texarkana
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
- Onna FeuchterSouthlake$108K
- Stephanie AgrellaRound Rock$102K
- Sue RankinAmarillo$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.